Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Test interpretation and treatment decisions must be confirmed with a qualified healthcare provider. Read the full policy at disclaimer policy.
","image":["/images/healthcarentsickcarestore.shop/images/product/hla-b-5701-testing-1.avif"],"sku":"hla-b-5701-testing","brand":{"@type":"Brand","name":"healthcare nt sickcare"},"offers":{"@type":"AggregateOffer","lowPrice":3699,"highPrice":3699,"priceCurrency":"USD","availability":"https://schema.org/InStock","url":"https://healthcarentsickcarestore.shop/products/hla-b-5701-testing","offerCount":1}}
HLA-B*5701 Genetic Test
HLA-B*5701 Test: Genetic Screening for Drug Hypersensitivity
Direct answer: The HLA-B*5701 test detects a specific genetic marker to identify individuals at risk of severe allergic reactions to certain medicines, especially the HIV drug abacavir.
HLA-B*5701 is a human leukocyte antigen gene variant linked to immune-mediated drug hypersensitivity. People carrying this marker can develop serious reactions if treated with abacavir or related medications. This test is advised before starting specific antiviral therapy or when previous unexplained drug reactions are reported. Sample collection is available through our Home Collection Facility across Pune or at our Direct Walk-in Facility in Aundh and nearby areas.
Why is the HLA-B*5701 test advised?
Direct answer: This test helps prevent serious drug-induced allergic reactions by identifying genetic risk before treatment.
Doctors use HLA-B*5701 results to safely guide medication selection and avoid hypersensitivity reactions. Learn more about genetic and immune-related testing in our health articles, review sample instructions in test preparation guides, or compare preventive screening options on comparison resources.
Clinical reference
For external medical guidance on HLA-B*5701 and abacavir hypersensitivity, visit the NCBI pharmacogenetic reference.
Frequently Asked Questions
When should I do an HLA-B*5701 test?
This test is advised before starting abacavir-based HIV treatment or if drug allergy risk needs evaluation.
Is fasting required before this test?
Fasting is not required. You may follow your normal diet before sample collection.
What does a positive HLA-B*5701 result mean?
A positive result indicates higher risk of severe allergic reaction to certain medicines and alternative drugs are recommended.
Which symptoms relate to drug hypersensitivity?
Fever, skin rash, breathing difficulty or sudden illness after medication intake may indicate hypersensitivity risk.
Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Test interpretation and treatment decisions must be confirmed with a qualified healthcare provider. Read the full policy at disclaimer policy.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
HLA-B*5701 Test: Genetic Screening for Drug Hypersensitivity
Direct answer: The HLA-B*5701 test detects a specific genetic marker to identify individuals at risk of severe allergic reactions to certain medicines, especially the HIV drug abacavir.
HLA-B*5701 is a human leukocyte antigen gene variant linked to immune-mediated drug hypersensitivity. People carrying this marker can develop serious reactions if treated with abacavir or related medications. This test is advised before starting specific antiviral therapy or when previous unexplained drug reactions are reported. Sample collection is available through our Home Collection Facility across Pune or at our Direct Walk-in Facility in Aundh and nearby areas.
Why is the HLA-B*5701 test advised?
Direct answer: This test helps prevent serious drug-induced allergic reactions by identifying genetic risk before treatment.
Doctors use HLA-B*5701 results to safely guide medication selection and avoid hypersensitivity reactions. Learn more about genetic and immune-related testing in our health articles, review sample instructions in test preparation guides, or compare preventive screening options on comparison resources.
Clinical reference
For external medical guidance on HLA-B*5701 and abacavir hypersensitivity, visit the NCBI pharmacogenetic reference.
Frequently Asked Questions
When should I do an HLA-B*5701 test?
This test is advised before starting abacavir-based HIV treatment or if drug allergy risk needs evaluation.
Is fasting required before this test?
Fasting is not required. You may follow your normal diet before sample collection.
What does a positive HLA-B*5701 result mean?
A positive result indicates higher risk of severe allergic reaction to certain medicines and alternative drugs are recommended.
Which symptoms relate to drug hypersensitivity?
Fever, skin rash, breathing difficulty or sudden illness after medication intake may indicate hypersensitivity risk.
Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Test interpretation and treatment decisions must be confirmed with a qualified healthcare provider. Read the full policy at disclaimer policy.
